tiprankstipranks
Trending News
More News >
Rocket Lab Usa, Inc. (RKLB)
NASDAQ:RKLB
US Market

Rocket Lab USA (RKLB) AI Stock Analysis

Compare
13,835 Followers

Top Page

RKLB

Rocket Lab USA

(NASDAQ:RKLB)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$73.00
▲(4.09% Upside)
Action:ReiteratedDate:02/27/26
The score is driven mainly by improving operating fundamentals (strong growth and gross-margin expansion) but constrained by persistent losses and significant cash burn. The latest earnings call adds support via strong backlog, major contract momentum, and confident near-term revenue guidance, while technicals and valuation provide limited help given negative momentum signals and the lack of profitability.
Positive Factors
Revenue Growth & Margin Expansion
Sustained revenue scaling with meaningful gross-margin expansion signals improving unit economics and stronger pricing or cost discipline across launch and space-systems. These structural improvements increase the odds of eventual operating leverage as R&D and Neutron spend normalize.
Large Backlog & Government Prime Contract
A record backlog anchored by a large SDA prime award provides multi-year revenue visibility and production planning leverage. Being a prime on national-security programs diversifies customers, deepens defense relationships, and can create recurring subsystem and sustainment revenue.
Improving Balance Sheet & Liquidity
Lower leverage and a ~$1.1B liquidity buffer reduce near-term refinancing risk and support continued Neutron development and SDA execution. A stronger capital base increases flexibility to invest in vertical integration and absorb program timing variability.
Negative Factors
Persistent Negative Cash Flow
Material and continuing cash burn means the company remains dependent on external financing or equity issuance to fund operations and Neutron development. This elevates dilution and execution risk if cash outflows persist before sustained positive operating cash flow is achieved.
Neutron Program Execution Risk
A manufacturing defect and subsequent schedule slip increase development cost, delay revenue from a key growth platform, and require process changes (AFP). Neutron execution uncertainty raises the likelihood of further timing slippage, higher CapEx, and stretched cash consumption over a longer horizon.
Lumpy Space Systems Revenue & Subcontractor Risk
Dependence on subcontractor performance and ASC 606 timing produces uneven Space Systems revenue and margins. This reduces predictability of cash flows and can cause quarter-to-quarter margin mix swings, pressuring planning and making backlog-to-revenue conversion uncertain.

Rocket Lab USA (RKLB) vs. SPDR S&P 500 ETF (SPY)

Rocket Lab USA Business Overview & Revenue Model

Company DescriptionRocket Lab USA, Inc., a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets. It also designs, manufactures, and sells Electron small orbital launch vehicles and the Photon satellite platforms, as well as developing the Neutron 8-ton payload class launch vehicle; conducts remote launch activities; and designs and manufactures a range of components and subsystems for the Photon family of spacecraft and broader merchant spacecraft components. The company serves commercial, aerospace prime contractors, and government customers. The company was founded in 2006 and is headquartered in Long Beach, California.
How the Company Makes MoneyRocket Lab generates revenue through multiple streams primarily focused on its launch services and satellite solutions. The main revenue source comes from the launch contracts it secures with commercial, government, and international customers to transport small satellites into orbit using its Electron rocket. Additionally, Rocket Lab derives income from the sales and services associated with its Photon satellite platform, which includes satellite design, manufacturing, and mission management. Significant partnerships, such as collaborations with NASA and various commercial entities, enhance its market presence and contribute to its earnings by securing a steady pipeline of launch contracts and satellite deployments.

Rocket Lab USA Key Performance Indicators (KPIs)

Any
Any
Revenue by Type
Revenue by Type
Shows how revenue is generated from different products or services, highlighting the company's diversification and potential areas of growth.
Chart InsightsRocket Lab USA's revenue has shown a strong upward trend, particularly in the 'Over-Time' category, reflecting robust demand for their space systems. Despite a recent dip in 'Point-In-Time' revenue, the company's strategic expansions and record backlog of launches signal sustained growth. The earnings call highlights challenges in launch services due to delays but underscores optimism with a strong financial outlook and significant advancements in their Neutron program. Investors should watch for the impact of these developments on future revenue and margin improvements.
Data provided by:The Fly

Rocket Lab USA Earnings Call Summary

Earnings Call Date:Feb 26, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call conveyed strong commercial and financial momentum — record revenue, record backlog, margin expansion, market leadership in small launch, a material SDA prime contract ($816M), successful high-profile missions (ESCAPADE), strategic acquisitions and continued Neutron hardware qualification progress. Counterbalancing these positives were meaningful near-term program risks and cash consumption: a Stage 1 tank rupture on Neutron that pushed the first launch target to Q4 2026, elevated R&D and CapEx for Neutron, negative operating/free cash flow in Q4, and some lumpy Space Systems revenue tied to subcontractor performance and ASC 606 timing. Overall the business appears to be scaling with solid liquidity (~$1.1B) and transformational opportunities (SDA, vertical integration, new solar tech), while managing expected execution and cash-flow challenges as Neutron development continues.
Q4-2025 Updates
Positive Updates
Record Annual and Quarterly Revenue
Full-year 2025 revenue of $602.0M, representing 38% year-over-year growth; Q4 2025 revenue of $180.0M, up 36% year-over-year and up 16% sequentially.
Record Backlog and Strong Bookings
Total backlog at quarter-end of ~$1.85B (record). Management cited ~73% growth versus the same time in 2024 and ~69% sequential growth noted in remarks, driven materially by the SDA Tranche III award; added 30+ new launches to the manifest.
Gross Margin Expansion
Q4 GAAP gross margin 38.0% and Q4 non-GAAP gross margin 44.3%; full-year GAAP gross margin 34.4% (up ~780 basis points YoY) and full-year non-GAAP 39.7% (up ~770 basis points YoY).
Launch Cadence and Market Leadership
Company launched a record 21 missions (Electron + HASTE) in 2025 and a record 7 launches in Q4; conducted 3 successful HASTE missions in 2025 with additional HASTE on the pad; management reiterated Rocket Lab as the leading reliable small-launch provider.
Large SDA Tranche III Contract Win
Awarded an $816M contract from the Space Development Agency to build 18 spacecraft (tracking/missile warning sensors). Combined SDA awards now exceed ~$1.3B; potential additional subsystem capture tied to Tranche III could add up to ~ $1B in addressable opportunity.
Successful High-Profile Missions and Programs
Delivered the ESCAPADE twin satellites to Mars (mission successfully commissioned and handed to mission team shortly); LOXSAT spacecraft completed and headed toward launch; record growth across Space Systems component businesses.
Strategic Acquisitions and Vertical Integration
Acquired Geost (2025), Optical Support, Inc. (Q1 2026), and Precision Components Limited (closed today) to strengthen payload, optical, and manufacturing capabilities and reduce supplier risk; raised $280.6M via ATM proceeds to support M&A and scaling.
Neutron Program Qualification Progress
Major Neutron hardware and subsystems have passed qualification during the quarter (fairing, thrust structure, second stage integration and interstage qualification work, hardware arriving at Wallops), Archimedes engine test program progressing aggressively toward flight readiness.
Strong Liquidity Position
Ending cash, cash equivalents, restricted cash and marketable securities of ~$1.1B at quarter-end, supported by $280.6M ATM proceeds and convertible note conversions that reduced indebtedness.
Product Innovation — Space-Optimized Silicon Solar Arrays
Announced a space-optimized silicon solar array (and hybrid arrays combining silicon and high-efficiency cells) designed to lower $/W and enable mass-manufacturable, gigawatt-scale power solutions for large constellations and emerging space data center concepts.
Negative Updates
Neutron Stage 1 Tank Rupture and Schedule Impact
A Stage 1 tank ruptured during a hydrostatic test due to a manufacturing defect in a hand-laid joint; management moved to automated fiber placement (AFP) production to eliminate the root cause. As a result Neutron's first launch is now targeted for Q4 2026 (slip) and program resources were reallocated to resolve the issue.
Negative Operating and Free Cash Flow
Q4 2025 GAAP operating cash flow was an outflow of $64.5M and non-GAAP free cash flow was a use of $114.2M; management expects elevated cash consumption to continue in 2026 driven by Neutron development, infrastructure and SDA procurement timing.
Sequential Decline in Space Systems Revenue
Space Systems revenue in Q4 was $103.8M, down 9.1% sequentially (decline driven by Satellite Platforms and Solar businesses and timing/nonlinearity of ASC 606 revenue recognition).
Widening GAAP Loss Per Share (Sequential)
Q4 GAAP EPS loss widened to $(0.09) versus $(0.03) in Q3; management attributed most of the sequential difference to a $41M tax benefit recorded in the prior quarter (partial release of valuation allowance tied to acquisition accounting).
Supply Chain and Rev-Recognition Lumpy Risk
Management highlighted that Space Systems backlog and revenue recognition are lumpy and gated by subcontractor deliveries; rev-rec conversion (management estimate ~37% of backlog converting in next 12 months) depends on third-party on-time performance, motivating further vertical integration.
Regulatory Uncertainty on Mynaric Acquisition
The Mynaric acquisition remains under German regulatory review with no update yet — introduces timing and execution uncertainty for an acquisition described as strategically important for optical terminals.
Elevated R&D and CapEx Driven by Neutron
Q4 GAAP operating expenses were $119.3M (below guidance range but up sequentially), R&D rose approximately $8.1M QoQ and Q4 purchases of property, equipment & capitalized software were $49.7M (up $3.8M QoQ); management expects elevated CapEx and peak Neutron R&D in Q1 2026.
Potential Margin Mix Pressure from Large Programs
Guidance indicates modest gross margin headwinds in Q1 2026 (GAAP 34–36%, non‑GAAP 39–41%) driven by a greater mix of Space Systems revenue (lower-margin, large government programs) versus higher-margin Launch; margins may be volatile quarter-to-quarter depending on mix.
Company Guidance
Rocket Lab guided Q1 2026 revenue of $185–$200M (midpoint ~7% QoQ growth, +57% YoY), GAAP gross margin of 34–36% and non‑GAAP gross margin of ~39–41% (modest sequential decline), GAAP operating expenses of $120–$126M and non‑GAAP operating expenses of $106–$112M, GAAP and non‑GAAP net interest income of ~$8M, adjusted EBITDA loss of $21–$27M, and basic weighted average shares of ~605M (including ~46M convertible preferred; ~23M shares converted so far with ~7.5M of the original convertible note shares remaining); management expects Q1 to mark peak Neutron R&D spending, continued negative non‑GAAP free cash flow driven by Neutron development, and noted that ~37% of current backlog is expected to convert to revenue within 12 months.

Rocket Lab USA Financial Statement Overview

Summary
Strong revenue scaling and improved gross margins support the growth story, and leverage looks more manageable. However, the company remains materially loss-making and cash flow is the key weakness, with deeply negative operating cash flow and worsening free-cash-flow burn in 2025.
Income Statement
56
Neutral
Revenue growth has accelerated meaningfully, with sales rising from $35.2M (2020) to $601.8M (2025), including a strong +8.5% growth rate in 2025 versus a modest +0.8% in 2024. Profitability is improving at the gross level (gross margin expanded from negative in 2020–2021 to ~34% in 2025), indicating better unit economics and scale benefits. However, the company remains loss-making with net margins still materially negative (about -33% in 2025) and operating profitability still pressured, suggesting ongoing heavy operating spend and limited near-term earnings power.
Balance Sheet
63
Positive
Leverage appears manageable in the latest year, with debt-to-equity improving to ~0.15 in 2025 versus ~1.22 in 2024, and equity rising to ~$1.72B alongside total assets of ~$2.32B. This provides a stronger capital base to support growth and investment. The key weakness is continued negative returns on equity (about -11.5% in 2025), reflecting that profitability has not yet caught up to the balance sheet expansion, and prior-year leverage volatility raises some caution around capital structure changes over time.
Cash Flow
41
Neutral
Cash generation remains a clear weak spot: operating cash flow is negative across all years shown, including -$165.5M in 2025, and free cash flow is also negative, deteriorating to -$321.8M in 2025. While free cash flow growth is positive in 2025 (+39.0%), the absolute burn increased versus 2024, implying higher investment and/or working-capital needs. A positive offset is that free cash flow is consistently less negative than net income (free cash flow to net income > 1), but the business is still reliant on external funding until operating cash flow turns sustainably positive.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue601.80M436.21M244.59M211.00M62.24M
Gross Profit207.18M116.15M51.41M18.99M-1.89M
EBITDA-155.47M-151.80M-144.93M-95.20M-91.20M
Net Income-198.21M-190.18M-182.57M-135.94M-117.32M
Balance Sheet
Total Assets2.32B1.18B941.21M989.12M980.85M
Cash, Cash Equivalents and Short-Term Investments1.02B418.99M244.77M471.79M690.96M
Total Debt252.24M468.42M176.69M152.78M128.43M
Total Liabilities602.62M801.89M386.67M315.92M282.40M
Stockholders Equity1.72B382.45M554.54M673.21M698.45M
Cash Flow
Free Cash Flow-321.81M-115.98M-153.57M-148.95M-97.49M
Operating Cash Flow-165.52M-48.89M-98.87M-106.54M-71.79M
Investing Cash Flow-347.40M-98.33M12.02M-346.08M-92.13M
Financing Cash Flow1.07B256.68M7.37M2.04M799.94M

Rocket Lab USA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price70.13
Price Trends
50DMA
77.35
Negative
100DMA
66.16
Positive
200DMA
53.38
Positive
Market Momentum
MACD
-1.82
Positive
RSI
46.03
Neutral
STOCH
42.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RKLB, the sentiment is Negative. The current price of 70.13 is below the 20-day moving average (MA) of 71.45, below the 50-day MA of 77.35, and above the 200-day MA of 53.38, indicating a neutral trend. The MACD of -1.82 indicates Positive momentum. The RSI at 46.03 is Neutral, neither overbought nor oversold. The STOCH value of 42.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RKLB.

Rocket Lab USA Risk Analysis

Rocket Lab USA disclosed 61 risk factors in its most recent earnings report. Rocket Lab USA reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Rocket Lab USA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
56
Neutral
$3.70B-45.298.07%33.37%
56
Neutral
$8.57B-17.57-31.83%16.89%-4.41%
52
Neutral
$40.81B-186.77-18.84%52.42%-1.33%
51
Neutral
$1.72B-4.01-52.00%-0.63%-163.11%
49
Neutral
$1.07B-6.63-115.63%-33.69%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RKLB
Rocket Lab USA
71.91
51.51
252.50%
EVEX
Eve Holding
3.08
-0.93
-23.19%
RDW
Redwire
9.28
-4.84
-34.28%
PL
Planet Labs PBC
26.00
21.62
493.61%
LUNR
Intuitive Machines
18.62
4.51
31.96%

Rocket Lab USA Corporate Events

Business Operations and StrategyProduct-Related Announcements
Rocket Lab Updates Neutron Rocket After Test Tank Rupture
Negative
Jan 22, 2026

On January 21, 2026, Rocket Lab reported that qualification testing of the Stage 1 tank for its in-development Neutron medium-lift rocket resulted in a rupture during a hydrostatic pressure trial, an event the company framed as a not-uncommon outcome of pushing hardware beyond operating limits in order to validate structural integrity and safety margins. Rocket Lab said there was no significant damage to test structures or facilities, the next Stage 1 tank is already in production, and the broader Neutron development campaign is continuing while engineers review test data to determine the impact on the rocket’s launch schedule, with investors and customers awaiting further clarity on timing at the company’s upcoming fourth-quarter 2025 earnings update in February.

The most recent analyst rating on (RKLB) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Rocket Lab USA stock, see the RKLB Stock Forecast page.

Business Operations and Strategy
Rocket Lab Wins Landmark $816 Million SDA Satellite Contract
Positive
Dec 19, 2025

On December 19, 2025, Rocket Lab announced it had secured an $816 million prime contract from the U.S. Space Development Agency to design, manufacture, operate and sustain 18 missile-defense satellites for the Tracking Layer Tranche 3 constellation, with work starting immediately and final satellite delivery expected in 2029. The award, which follows a prior $515 million SDA contract and can expand toward $1 billion when including additional subsystem sales to other Tranche 3 primes, marks Rocket Lab’s largest contract to date and reinforces its emergence as a vertically integrated, disruptive prime contractor in U.S. national security space, challenging legacy aerospace players and deepening its role in the U.S. Space Force’s missile warning and tracking architecture.

The most recent analyst rating on (RKLB) stock is a Hold with a $49.00 price target. To see the full list of analyst forecasts on Rocket Lab USA stock, see the RKLB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 27, 2026